The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma
Open accessAbstract
age peak in the 6th and 7th decades of life [1] .The frequency of multicentricity lies between 26 and 30% [3, 4] and 15-29% of tumors are associated with other non-carcinoid malignancies [5][6][7] .The WHO classification subdivides jejunal-ileal tumors, similar to other gastroenteropancreatic endocrine tumors, into three general categories [8] : (1) well-differentiated endocrine tumor (carcinoid) of benign behavior (confined to the mucosasubmucosa, non-angioinvasive, ! 1 cm in size) or uncertain behavior (non-functioning, confined to mucosasubmucosa, 1 1 cm in size, or angioinvasive); (2) well-differentiated endocrine carcinoma (malignant carcinoma) with low-grade malignant behavior, deeply invasive (muscularis propria or beyond) or with metastases, and (3) poorly-differentiated endocrine carcinoma (small-cell carcinoma), high-grade malignant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iddan, G., Meron, G., Glukhovsky, A., & Swain, P. (2000) · Nature · doi:10.1038/35013140 · Cited by 3,066
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Self-citationTNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Self-citationAn analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Eble, J. N. (2004) · Medical Entomology and Zoology · Cited by 1,152
Carcinoid TumorsAn analysis of 2837 cases
Godwin, J. D. (1975) · Cancer · doi:10.1002/1097-0142(197508)36:2<560::aid-cncr2820360235>3.0.co;2-4 · Cited by 1,106
Sarmiento, J. M., Heywood, G., Rubin, J., Ilstrup, D. M., Nagorney, D. M., & Que, F. G. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00230-8 · Cited by 773
Kwekkeboom, D. J., Teunissen, J. J., Bakker, W. H., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., Esser, J.-P., Kam, B. L., & Krenning, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.066 · Cited by 657
Self-citationHepatic neuroendocrine metastases: does intervention alter outcomes?1
Chamberlain, R. S., Canes, D., Brown, K. T., Saltz, L., Jarnagin, W., Fong, Y., & Blumgart, L. H. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00222-2 · Cited by 622
Life history of the carcinoid tumor of the small intestine
Moertel, C. G., Sauer, W. G., Dockerty, M. B., & Baggenstoss, A. H. (1961) · Cancer · doi:10.1002/1097-0142(196109/10)14:5<901::aid-cncr2820140502>3.0.co;2-q · Cited by 555
Hofmann, M., Maecke, H., Börner, A., Weckesser, E., Schöffski, P., Oei, M., Schumacher, J., Henze, M., Heppeler, A., Meyer, G., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100639 · Cited by 544
Faiss, S., Pape, U.-F., Böhmig, M., Dörffel, Y., Mansmann, U., Golder, W., Riecken, E. O., & Wiedenmann, B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.142 · Cited by 501
Self-citationKarnofsky memorial lecture. An odyssey in the land of small tumors.
Moertel, C. G. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1502 · Cited by 473
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P., Konijnenberg, M. W., Srinivasan, A., Erion, J. L., Schmidt, M. A., Bugaj, J. L., de Jong, M., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100574 · Cited by 471
Self-citationHepatic resection for metastatic neuroendocrine carcinomas
Que, F. G., Nagorney, D. M., Batts, K. P., Linz, L. J., & Kvols, L. K. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80107-x · Cited by 462
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
Waldherr, C., Pless, M., Maëcke, H. R., Schumacher, T., Crazzolara, A., Nitzsche, E. U., Haldemann, A. R., & Mueller‐Brand, J. (2002) · PubMed · Cited by 445
Valkema, R., de Jong, M., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Lugtenburg, P. J., de Jong, F. H., Christiansen, A., Kam, B. L. R., de Herder, W. W., et al. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc/2002.31025 · Cited by 435
Self-citationWaldherr, C., Pless, M., Maecke, H. R., Haldemann, A., & Mueller-Brand, J. (2001) · Annals of Oncology · doi:10.1023/a:1011160913619 · Cited by 396
Rubin, J., Ajani, J., Schirmer, W., Venook, A. P., Bukowski, R., Pommier, R., Saltz, L., Dandona, P., & Anthony, L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.600 · Cited by 389
Cytoreductive hepatic surgery for neuroendocrine tumors.
Gp, M., Nagorney, D. M., Lk, K., Cg, M., & Cs, G. (1990) · PubMed · Cited by 381
Isolated Liver Metastases from Neuroendocrine Tumors: Does Resection Prolong Survival?
Chen, H., Hardacre, J. M., Uzar, A., Cameron, J. L., & Choti, M. A. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00099-4 · Cited by 371
Incidence trends and risk factors of carcinoid tumors: A nationwide epidemiologic study from Sweden
Hemminki, K., & Li, X. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2204::aid-cncr1564>3.0.co;2-r · Cited by 363
Arnold, R., Trautmann, M. E., Creutzfeldt, W., Benning, R., Benning, M., Neuhaus, C., Jürgensen, R., Stein, K., Schäfer, H., Bruns, C., et al. (1996) · Gut · doi:10.1136/gut.38.3.430 · Cited by 342
Self-citationOrlefors, H., Sundin, A., Garske, U., Juhlin, C., Oberg, K., Skogseid, B., Langstrom, B., Bergstrom, M., & Eriksson, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1938 · Cited by 329
Self-citationRolleman, E., Valkema, R., de Jong, M., Kooij, P., & Krenning, E. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0982-3 · Cited by 321
Self-citationBodei, L., Cremonesi, M., Zoboli, S., Grana, C., Bartolomei, M., Rocca, P., Caracciolo, M., Mäcke, H. R., Chinol, M., & Paganelli, G. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1023-y · Cited by 305
Di Bartolomeo, M., Bajetta, E., Buzzoni, R., Mariani, L., Carnaghi, C., Somma, L., Zilembo, N., Di Leo, A., & ITMO Association (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<402::aid-cncr25>3.0.co;2-4 · Cited by 296
NORHEIM, I., ÖBERG, K., THEODORSSON-NORHEIM, E., LINDGREN, P. G., LUNDQVIST, G., MAGNUSSON, A., WIDE, L., & WILANDER, E. (1987) · Annals of Surgery · doi:10.1097/00000658-198708000-00001 · Cited by 271
Saltz, L., Trochanowski, B., Buckley, M., Heffernan, B., Niedzwiecki, D., Tao, Y., & Kelsen, D. (1993) · Cancer · doi:10.1002/1097-0142(19930701)72:1<244::aid-cncr2820720143>3.0.co;2-q · Cited by 260
Long-Term Serotonin Administration Induces Heart Valve Disease in Rats
Gustafsson, B. I., Tømmerås, K., Nordrum, I., Loennechen, J. P., Brunsvik, A., Solligård, E., Fossmark, R., Bakke, I., Syversen, U., & Waldum, H. (2005) · Circulation · doi:10.1161/01.cir.0000159356.42064.48 · Cited by 257
Aggressive surgery for metastatic liver neuroendocrine tumors
Norton, J. A., Warren, R. S., Kelly, M. G., Zuraek, M. B., & Jensen, R. T. (2003) · Surgery · doi:10.1016/j.surg.2003.07.025 · Cited by 255
Arnold, R., Rinke, A., Klose, K.-J., Müller, H.-H., Wied, M., Zamzow, K., Schmidt, C., Schade-Brittinger, C., Barth, P., Moll, R., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00481-7 · Cited by 254
Self-citationBURKE, A. P., Thomas, R. M., Elsayed, A. M., et al. (1997) · PubMed · Cited by 244
111In- and 90Y-DOTA-Lanreotide: Results and implications of the MAURITIUS trial
Virgolini, I., Britton, K., Buscombe, J., Moncayo, R., Paganelli, G., & Riva, P. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31565 · Cited by 243
CARCINOID TUMOURS: Frequency in a Defined Population During a 12‐Year‐Period
Berge, T., & Linell, F. (1976) · Acta Pathologica Microbiologica Scandinavica Section A Pathology · doi:10.1111/j.1699-0463.1976.tb00122.x · Cited by 238
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study
Koopmans, K. P., de Vries, E. G., Kema, I. P., Elsinga, P. H., Neels, O. C., Sluiter, W. J., van der Horst-Schrivers, A. N., & Jager, P. L. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70801-4 · Cited by 237
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
Aparicio, T., Ducreux, M., Baudin, E., Sabourin, J.-C., De Baere, T., Mitry, E., Schlumberger, M., & Rougier, P. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00073-9 · Cited by 226
Wymenga, A. N. M., Eriksson, B., Salmela, P. I., Jacobsen, M. B., Van Cutsem, E. J. D. G., Fiasse, R. H., Välimäki, M. J., Renstrup, J., de Vries, E. G. E., & Öberg, K. E. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1111 · Cited by 226
Self-citationKölby, L., Persson, G., Franzén, S., & Ahrén, B. (2003) · British Journal of Surgery · doi:10.1002/bjs.4149 · Cited by 222
[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy
de Jong, M., Breeman, W. A. P., Bernard, B. F., Bakker, W. H., Schaar, M., van Gameren, A., Bugaj, J. E., Erion, J. L., Schmidt, M. A., Srinivasan, A., et al. (2001) · International Journal of Cancer · Cited by 210
Self-citationde Jong, M., Breeman, W. A., Bakker, W., Kooij, P. P. M., Bernard, B. F., Hofland, L. J., Visser, T. J., Srinivasan, A., Schmidt, M. A., Erion, J. L., et al. (1998) · PubMed · Cited by 209
Self-citationReceptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide
Paganelli, G., Zoboli, S., Cremonesi, M., Bodei, L., Ferrari, M., Grana, C., Bartolomei, M., Orsi, F., De Cicco, C., Mäcke, H. R., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100490 · Cited by 206
Ruszniewski, P., Ducreux, M., Chayvialle, J. A., Blumberg, J., Cloarec, D., Michel, H., Raymond, J. M., Dupas, J. L., Gouerou, H., Jian, R., et al. (1996) · Gut · doi:10.1136/gut.39.2.279 · Cited by 206
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
Kaltsas, G., Rockall, A., Papadogias, D., Reznek, R., & Grossman, A. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510015 · Cited by 206
Swain, P. (2003) · Gut · doi:10.1136/gut.52.suppl_4.iv48 · Cited by 197
The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors
Ducreux, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02003-7 · Cited by 196
Frank, M. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00146-x · Cited by 191
Eriksson, B., Renstrup, J., Imam, H., & Öberg, K. (1997) · Annals of Oncology · doi:10.1023/a:1008205415035 · Cited by 190
Self-citationRole of neuropeptides and serotonin in the diagnosis of carcinoid tumors
Feldman, J. M., & O'dorisio, T. M. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90583-8 · Cited by 184
Chemotherapy and biotherapy in the treatment of neuroendocrine tumours
Öberg, K. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s111 · Cited by 167
Moertel, C. G., Rubin, J., & Kvols, L. K. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.7.865 · Cited by 165
Surgical treatment of mid‐gut carcinoid tumors
Makridis, C., Öberg, K., Juhlin, C., Rastad, J., Johansson, H., Lörelius, L. E., & Åkerström, G. (1990) · World Journal of Surgery · doi:10.1007/bf01658532 · Cited by 161
Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook
Eriksson, B., & Öberg, K. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s31 · Cited by 160
Self-citationPrognostic variables in patients with gastrointestinal carcinoid tumours
McDermott, E. W. M., Gudurić, B., & Brennan, M. F. (1994) · British journal of surgery · doi:10.1002/bjs.1800810725 · Cited by 142
Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours
Janson, E. T., Ahlström, H. K., Andersson, T., & Öberg, K. E. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90060-f · Cited by 130
Familial carcinoid tumors and subsequent cancers: A nation-wide epidemiologic study from Sweden
Hemminki, K., & Li, X. (2001) · International Journal of Cancer · doi:10.1002/ijc.1473 · Cited by 130
Chinol, M., Bodei, L., Cremonesi, M., & Paganelli, G. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31563 · Cited by 127
Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR
Tomassetti, Migliori, Corinaldesi, & Gullo (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00738.x · Cited by 125
Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome
Westberg, G., Wängberg, B., Ahlman, H. K., Bergh, C. ‐., Suurküla, M. B., & Caidahl, K. (2001) · British journal of surgery · doi:10.1046/j.0007-1323.2001.01798.x · Cited by 121
Self-citationSurvival of Patients with Disseminated Midgut Carcinoid Tumors after Aggressive Tumor Reduction
Wängberg, B., Westberg, G., Tylén, U., et al. (1996) · World Journal of Surgery · doi:10.1007/s002689900136 · Cited by 114
Chemotherapy in the Treatment of Neuroendocrine Malignant Tumors
Rougier, P. R., & Mitry, E. (2000) · Digestion · doi:10.1159/000051859 · Cited by 111
Nguyen, A. P., Schaff, H. V., & Connolly, H. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-24174-2_51 · Cited by 104
Ardill, J. E. S., & Erikkson, B. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100459 · Cited by 103
de Jong, M., Breeman, W. A. P., Bernard, B. F., Bakker, W. H., Visser, T. J., Kooij, P. P. M., van Gameren, A., & Krenning, E. P. (2001) · PubMed · Cited by 102
Self-citationSlow-Release Lanreotide Treatment in Endocrine Gastrointestinal Tumors
Tomassetti, P., Migliori, M., & Gullo, L. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.465_q.x · Cited by 101
Progression of Metastases and Symptom Improvement from Laparotomy in Midgut Carcinoid Tumors
Makridis, C., Rastad, J., Öberg, K., & Åkerström, G. (1996) · World Journal of Surgery · doi:10.1007/s002689900137 · Cited by 97
Experience with Indium-111 and Yttrium-90-Labeled Somatostatin Analogs
Virgolini, I. J., Traub‐Weidinger, T., Novotny, C., Leimer, M., Fueger, B. J., Li, S., Patri, P., Pangerl, T., Angelberger, P., Raderer, M., et al. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023393756 · Cited by 97
Standardisation of imaging in neuroendocrine tumours: results of a European delphi process
Ricke, J., Klose, K.-J., Mignon, M., Öberg, K., & Wiedenmann, B. (2001) · European Journal of Radiology · doi:10.1016/s0720-048x(00)00187-x · Cited by 92
Self-citationRicci, S., Antonuzzo, A., Galli, L., Ferdeghini, M., Bodei, L., Orlandini, C., & Conte, P. (2000) · Annals of Oncology · doi:10.1023/a:1008383132024 · Cited by 90
Somatostatin Analogues for Somatostatin-Receptor-Mediated Radiotherapy of Cancer
Stolz, B., Smith-Jones, P. M., Albert, R., Tolcsvai, L., Briner, U., Ruser, G., Mäcke, H. R., Weckbecker, G., & Bruns, C. (2009) · Digestion · doi:10.1159/000201387 · Cited by 72
Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease
Zuetenhorst, J. M., Korse, C. M., Bonfrèr, J. M. G., Bakker, R., & Taal, B. G. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601816 · Cited by 72
Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
de Jong, M., Breeman, W. A. P., Bernard, H. F., Kooij, P. P. M., Slooter, G. D., van Eijck, C. H. J., Kwekkeboom, D. J., Valkema, R., Mäcke, H. R., & Krenning, E. P. (1999) · PubMed · Cited by 71
Self-citationJacobsen, M. B., Hanssen, L. E., Kolmannskog, F., Schrumpf, E., Vatn, M. H., & Bergan, A. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509096329 · Cited by 71
Norton, J. A. (2009) · Digestion · doi:10.1159/000201209 · Cited by 69
Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?
Välimäki, M. J., Järvinen, H., Salmela, P. I., Sane, T., Sjöblom, S. M., & Pelkonen, R. (1991) · Cancer · doi:10.1002/1097-0142(19910201)67:3<547::aid-cncr2820670302>3.0.co;2-j · Cited by 68
Interventional Treatment of Gastrointestinal Neuroendocrine Tumours
Ahlman, H. K., Wängberg, B., Jansson, S., Friman, S., Olausson, M., Tylén, U., & Nilsson, O. (2000) · Digestion · doi:10.1159/000051857 · Cited by 67
Self-citationThe Use of Chemotherapy in the Management of Neuroendocrine Tumors
Öberg, K. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30142-7 · Cited by 67
Peptide Hormones as Tumor Markers in Neuroendocrine Gastrointestinal Tumors
Eriksson, B. K., & Öberg, K. (1991) · Acta Oncologica · doi:10.3109/02841869109092404 · Cited by 66
Self-citationLeong, W. L., & Pasieka, J. L. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10062 · Cited by 63
Surgical Treatment of Carcinoid Tumors of the Small Bowel, Appendix, Colon and Rectum
Rothmund, M., & Kisker, O. (2009) · Digestion · doi:10.1159/000201207 · Cited by 53
Abdominal Surgery in Patients with Midgut Carcinoid Tumors
Åkerström, G., Makridis, C., & Johansson, H. (1991) · Acta Oncologica · doi:10.3109/02841869109092416 · Cited by 48
Cardiac manifestations in mid-gut carcinoid disease
Jacobsen, M. B., NITTER‐HAUGE, S., Bryde, P., & Hanssen, L. E. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060894 · Cited by 44
Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors
Pelley, R. J., & Bukowski, R. M. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199901000-00008 · Cited by 37
Fahey, T. J. (2006) · Yearbook of Surgery · doi:10.1016/s0090-3671(08)70429-4 · Cited by 33
Surgery for carcinoid tumours of the lower gastrointestinal tract
Goede, A., & Winslet, M. C. (2003) · Colorectal Disease · doi:10.1046/j.1463-1318.2003.00457.x · Cited by 19
Wajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4
Cited by
Pavel, M., O''Toole, D., Costa, F., Capdevila, J., Gross, D., Kianmanesh, R., Krenning, E., Knigge, U., Salazar, R., Pape, U.-F., et al. (2016) · Neuroendocrinology · doi:10.1159/000443167 · Cited by 1,041
Self-citationRamage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
Pavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 873
Self-citationZaknun, J. J., Bodei, L., Mueller-Brand, J., Pavel, M. E., Baum, R. P., Hörsch, D., O’Dorisio, M. S., O’Dorisiol, T. M., Howe, J. R., Cremonesi, M., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2330-6 · Cited by 818
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Oronsky, B., Ma, P. C., Morgensztern, D., & Carter, C. A. (2017) · Neoplasia · doi:10.1016/j.neo.2017.09.002 · Cited by 763
Metadata
- Authors
- Eriksson, B., Klöppel, G., Krenning, E., Ahlman, H., Plöckinger, U., Wiedenmann, B., Arnold, R., Auernhammer, C., Körner, M., Rindi, G., & Wildi, S.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2007-12-12
- Volume
- 87
- Issue
- 1
- Pages
- 8-19
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W1992543080
- Cited by
- 254
- References
- 87
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.